Elimination of intraluminal colonization by antibiotic lock in catheters.
Antibiotic lock (AL) technique for catheter related infection encompasses the filling of a catheter lumen with high concentrations of antibiotics for hours. The goal of AL therapy is to decontaminate the intraluminal surface of the catheter. However the duration of antibiotic therapy is not established. An in vitro model was designed to establish the time needed to eliminate intraluminal microbial colonization and to evaluate the efficacy of vancomycin in comparison with teicoplanin by using laboratory AL model. Human plasma was instilled into the catheters to allow deposition of fibrin and other products on the catheter wall. After 48 hours, the catheters were drained and inoculated with bacteria in tryptic soy broth. The catheters were then drained and filled with either (a) vancomycin saline solution (VSS) lock (b) teicoplanin saline solution (TSS) lock or (c) saline solution (SS) as the control and then incubated for 12 hours. After 12 hours incubation all the catheter were drained and filled with human plasma. Instillation of human plasma and AL was alternated every 12 hours to simulate clinical conditions. For each day three catheters, locked with VSS, TSS and SS were cultured for colony count. Microbial counts were expressed as total colony-forming units per longitudinal centimeters of catheter surface. A significant decrease in intraluminal catheter colonization started as early as day 1. At the end of 7th day catheters treated with VSS and TSS lock were completely sterile. The decrease of intraluminal colonization was similar in catheters treated with VSS and TSS lock. Also the decrease of intraluminal colonization were similar in catheter colonized with slime forming S. epidermidis and nonslime-forming S. epidermidis.
Oncu
Serkan
S
Department of Infectious Diseases and Clinical Microbiology, Adnan Menderes University, Medical Faculty, Aydin, Turkey. serkanoncu@hotmail.com
Oncu
Selcen
S
Ozturk
Barcin
B
Kurt
Ibrahim
I
Sakarya
Serhan
S
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001424:Bacterial Infections / Q000382:microbiology / Q000517:prevention & control*; D002404:Catheterization; D002455:Cell Division / Q000187:drug effects; D015169:Colony Count, Microbial; D006801:Humans; D010949:Plasma; D012965:Sodium Chloride / Q000494:pharmacology; D013212:Staphylococcus epidermidis / Q000166:cytology / Q000187:drug effects; D017334:Teicoplanin / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D012965:Sodium Chloride; D017334:Teicoplanin; D014640:Vancomycin